The Navy continued the tests for seven days, potentially causing at least one death. It was one of the first large-scale biological weapon trials that would be conducted under a “germ warfare testing program” that went on for 20 years, from 1949 to 1969. The goal “was to deter [the use of biological weapons] against the United States and its allies and to retaliate if deterrence failed,” the government explained later. “Fundamental to the development of a deterrent strategy was the need for a thorough study and analysis of our vulnerability to overt and covert attack.”

Cole, now the director of the Terror Medicine and Security Program at Rutgers New Jersey Medical School, tells Business Insider that this incident was “notable: first, because it was really early in the program … but also because of the extraordinary coincidence that took place at Stanford Hospital, beginning days after the Army’s tests had taken place.”

Hospital staff were so shocked at the appearance of a patient infected with a bacteria, Serratia marcescens, that had never been found in the hospital and was rare in the area, that they published an article about it in a medical journal. The patient, Edward Nevin, died after the infection spread to his heart.